Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Triple-Negative Breast Cancer
Interventions: DRUG: Vinorelbine|DRUG: Apatinib
Sponsor: Fudan University